Applied Therapeutics, Inc.
APLTNASDAQHealthcare
$0.10
+$0.00(+0.00%)
Market Cap$14862969
P/E Ratio—
52W High$1.5
52W Low$0.09
Applied Therapeutics, Inc. (APLT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · APLT · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.46M | $9.99M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $48.74M | $53.91M | $0.44M | $0.00M | $0.00M |
| Gross Profit | ($48.29M) | ($43.91M) | ($0.44M) | $0.00M | $0.00M |
| Gross Margin %(computed) | — | -439.43% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $48.74M | $53.91M | $55.63M | $62.57M | $61.79M |
| G&A Expenses | $56.01M | $20.62M | $27.32M | $43.05M | $32.68M |
| Total Operating Expenses | $56.01M | $20.62M | $82.51M | $105.62M | $94.47M |
| Operating Income | ($104.30M) | ($64.53M) | ($82.95M) | ($105.62M) | ($94.47M) |
| Operating Margin %(computed) | — | -645.80% | — | — | — |
| Interest Income | $3.53M | $1.37M | $0.69M | $0.56M | $0.56M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.56M | $0.56M |
| Income Before Tax | ($105.62M) | ($119.76M) | ($82.51M) | ($105.58M) | ($93.96M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($105.62M) | ($119.76M) | ($82.51M) | ($105.58M) | ($93.96M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.76 | $-1.42 | $-2.18 | $-4.12 | $-4.28 |
| Wtd Avg Shares | 139.53M | 84.24M | 37.83M | 25.60M | 21.97M |
| EBITDA | ($104.30M) | ($64.53M) | ($82.07M) | ($105.62M) | ($94.47M) |
| EBITDA Margin %(computed) | — | -645.79% | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Applied Therapeutics, Inc. data
About Applied Therapeutics, Inc. (APLT) Income Statement
Applied Therapeutics, Inc. (APLT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, APLT reported revenue of $0.00B, gross profit of ($0.05B) (gross margin -10612.97%), and net income of ($0.11B) — a net profit margin of -23214.07%.
Frequently asked questions
APLT · 4 questionsApplied Therapeutics, Inc. (APLT) reported revenue of $0.00B for 2024, down 95.4% year-over-year.
APLT revenueAPLT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09